Table 3.
Assessment and comparison of AGREE-HS domains
| AGREE-HS score, median (IQR) |
P-value* |
||||||
|---|---|---|---|---|---|---|---|
|
|
CDC
|
ECDC
|
WHO
|
Overall
|
CDC vs ECDC
|
CDC vs WHO
|
ECDC vs WHO
|
|
Topic
|
4.00 (3.00-6.00) |
6.00 (4.25-6.00) |
6.00 (5.00-7.00) |
<0.001 |
<0.001 |
<0.001 |
0.801 |
|
Participants
|
1.00 (1.00-1.00) |
2.00 (2.00-2.00) |
3.00 (2.00-3.00) |
<0.001 |
<0.001 |
<0.001 |
0.010 |
|
Methods
|
1.00 (1.00-2.00) |
2.50 (2.00-3.00) |
3.00 (2.00-4.00) |
<0.001 |
<0.001 |
<0.001 |
0.534 |
|
Recommendations
|
3.00 (2.00-3.00) |
4.00 (3.00-5.00) |
4.00 (3.00-5.00) |
<0.001 |
<0.001 |
<0.001 |
0.964 |
| Implementability | 2.00 (2.00-3.00) | 3.00 (2.25-4.00) | 3.00 (3.00-5.00) | <0.001 | 0.001 | <0.001 | 0.587 |
AGREE-HS – Appraisal of Guidelines for Research and Evaluation – Health Systems, IQR – interquartile range, WHO – World Health Organization, ECDC – European Centre for Disease Control and Prevention, CDC – United States Centers for Disease Control and Prevention
*Kruskal-Wallis test for overall and Dwass-Steel-Critchlow-Fligner test for pairwise comparison.